(6-Phenoxypyridin-3-yl)boronic acid, 95.0%, 250mg

4-methyl-5-(2-thienylmethyl)-4H-1,2,4-triazole-3-thiol, 95.0%, 5g

tert-Butyl (2S)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]-5-oxopyrrolidine-1-carboxylate, 95%, 500mg

3-Chloro-6-(piperazin-1-yl)pyridazine hydrochloride, 95.0%, 10g

4-(2-oxopyrrolidin-1-yl)pyridine-2-carboxylic acid, >95%, 1g

L-Noradrenaline, 98%, 1g

Accessories Caps for digital transfer cap, Gesch. for, Volume 2000–10000 μl, 10 Pieces

(S)-3-((tert-Butoxycarbonyl)amino)-3-(4-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 100mg

2-(Carboxymethyl)-4-nitrobenzoic acid, 95.0%, 5g

Ethyl 4-(4-Chloro-2-methoxyphenyl)-4-oxobutanoate, 97.0%, 1g

5-CHLORO-3-METHYL-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDINE, 95.0%, 500mg

MCC950 sodium, 100mg

(S)-2-Phenethylpiperazine dihydrochloride, 97.0%, 250mg